Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Andrea M Burden"'
Autor:
Mohamad I Nasser, Annika Vestergaard Kvist, Peter Vestergaard, Richard Eastell, Andrea M Burden, Morten Frost
Publikováno v:
JBMR Plus, Vol 7, Iss 11, Pp n/a-n/a (2023)
ABSTRACT The incidence of major osteoporotic fractures has declined in men and women in Western countries over the last two decades. Although fracture risk is higher in persons with diabetes mellitus, trends of fractures remain unknown in men and wom
Externí odkaz:
https://doaj.org/article/ccb76900420c4e56bf0edc9a08e287d1
Autor:
Axel Finckh, Kim Lauper, Andrea M Burden, Thomas Hügle, Enriqueta Vallejo-Yagüe, Theresa Burkard
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objectives Treatment response is worse in obese patients with rheumatoid arthritis (RA), including patients on weight-adjusted therapies like infliximab. We aimed to assess the association between body mass index (BMI) and changes in RA disease activ
Externí odkaz:
https://doaj.org/article/cf24e3f5ab6443f49bec772e91a3fd2c
Publikováno v:
PLoS Computational Biology, Vol 19, Iss 6, p e1011073 (2023)
Cycling of biologic or targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) in rheumatoid arthritis (RA) patients due to non-response is a problem preventing and delaying disease control. We aimed to assess and validate treatment res
Externí odkaz:
https://doaj.org/article/627305547859459cb0f36d9f89bb7efe
Autor:
Enriqueta Vallejo-Yagüe, Julia N Pfund, Theresa Burkard, Carole Clair, Raphael Micheroli, Burkhard Möller, Axel Finckh, Andrea M Burden
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0275026 (2022)
ObjectiveTo compare the likelihood of achieving remission between men and women with rheumatoid arthritis (RA) after starting their first biologic or targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD).MethodsThis cohort study in the
Externí odkaz:
https://doaj.org/article/3f74ab85015143a69a9a1e3a3dccc71f
Autor:
Lukas Higi, Angela Lisibach, Patrick E Beeler, Monika Lutters, Anne-Laure Blanc, Andrea M Burden, Dominik Stämpfli
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259864 (2021)
BackgroundReadmission prediction models have been developed and validated for targeted in-hospital preventive interventions. We aimed to externally validate the Potentially Avoidable Readmission-Risk Score (PAR-Risk Score), a 12-items prediction mode
Externí odkaz:
https://doaj.org/article/6160960cb1214e3c9ea9dda69423d784
Autor:
Aleksandra Stanisic, Dominik Stämpfli, Angela E. Schulthess Lisibach, Monika Lutters, Andrea M. Burden
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 8 (2024)
AIMS OF THE STUDY: Opioid prescriptions have increased in Switzerland, even though current guidelines warn of their harms. If opioids for postoperative analgesia are not tapered before hospital discharge, patients are at risk of adverse events such a
Externí odkaz:
https://doaj.org/article/ae8c2acf469b4d9ab3d5a208924d65c3
Publikováno v:
Bone Reports, Vol 20, Iss , Pp 101730- (2024)
Observational studies of osteoporosis medications can provide critical real-world evidence (RWE) that fills knowledge gaps left by clinical trials. However, careful consideration of study design is needed to yield reliable estimates of association. I
Externí odkaz:
https://doaj.org/article/22e6c53567d3491e841c312a40566e12
Autor:
Maria L. Faquetti, Laura Slappendel, Hélène Bigonne, Francesca Grisoni, Petra Schneider, Georg Aichinger, Gisbert Schneider, Shana J. Sturla, Andrea M. Burden
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract INTRODUCTION Janus kinase (JAK) inhibitors were recently identified as promising drug candidates for repurposing in Alzheimer's disease (AD) due to their capacity to suppress inflammation via modulation of JAK/STAT signaling pathways. Beside
Externí odkaz:
https://doaj.org/article/32707a26a2ea43c8a6c975a581110aff
Autor:
Dominik Stämpfli, Adrian Martinez-De la Torre, Sophie Du Pasquier, Danielle Stegmann, Andrea Brügger, Andrea M. Burden
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1 (2020)
Background In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since 2015, Swiss pharmacists are allowed to vaccinate healthy adults after acquiring a certificate of compete
Externí odkaz:
https://doaj.org/article/157f8eac8e96401dbc5d8f021b6c1457
Autor:
Dominik Stämpfli, Adrian Martinez-De la Torre, Elodie Simi, Sophie Du Pasquier, Jérôme Berger, Andrea M. Burden
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1320 (2021)
In response to the coronavirus disease 2019 (COVID-19) pandemic, Swiss health authorities approved and ordered two mRNA vaccines in 2021. The canton of Zurich was the second in Switzerland to allow community pharmacists to administer the COVID-19 mRN
Externí odkaz:
https://doaj.org/article/dbdc861ee4e04291a89d09ec7206647f